share_log

Needham Initiates Coverage On Evolent Health With Buy Rating, Announces Price Target of $15

Needham Initiates Coverage On Evolent Health With Buy Rating, Announces Price Target of $15

Needham对Evolent Health启动覆盖,给予买入评级,并宣布目标价为15美元。
Benzinga ·  01/10 19:27  · 评级/大行评级

Needham analyst Matthew Sheerin initiates coverage on Evolent Health (NYSE:EVH) with a Buy rating and announces Price Target of $15.

Needham 分析师Matthew Sheerin 对Evolent Health(纽交所:EVH)启动覆盖,给予买入评级,并宣布目标价格为15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发